Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects.

Pedro Saddi-Rosa 1 Carolina Oliveira 1 Felipe Crispim 1 Fernando Giuffrida 1, 2 Valter De Lima 3 José Vieira 1 Alessandro Doria 4 Gilberto Velho 5 André Reis 1, *
* Auteur correspondant
1 Diabetes Center
2 Centro de Endocrinologia do Estado da Bahia
3 Cardiology Unit
4 Research Division
5 Déterminants génétiques du diabète de type 2 et de ses complications vasculaires
Abstract : BACKGROUND: Nicotinamide phosphoribosyltransferase (NAMPT) is the limiting enzyme in one of pathways of synthesis of Nicotinamide Adenine Dinucleotide, a redox coenzyme. NAMPT is considered as an insulin-mimetic factor and a potential regulatory factor in inflammatory and immune processes. Associations of circulating NAMPT levels with cardiovascular disease (CVD) and insulin resistance have been reported. We investigated association of circulating NAMPT levels and the rs9770242 NAMPT gene polymorphism with coronary artery disease (CAD). METHODS: We studied 594 Brazilian subjects undergoing a coronary angiography (49% of whom had type 2 diabetes). CAD, defined as stenosis greater than 50% in one major coronary vessel or branch, was observed in 68% of subjects. Genetic studies were also performed in 858 North-American Non-Hispanic White subjects with type 2 diabetes (49% with CAD). RESULTS: We observed an interaction between glycemic and CAD status on the comparison of NAMPT levels by CAD status. NAMPT levels were higher in type 2 diabetic patients with CAD as compared to those without CAD: 5.27 +/- 2.93 ng/ml vs. 4.43 +/- 2.94 ng/ml, p = 0.006 (mean +/- SD). NAMPT levels were not significantly different in non-diabetic subjects with or without CAD. The T-allele of rs9770242 was associated with CAD in the Brazilian cohort (OR 1.46, 95% CI 1.06 - 2.01, p = 0.02) while no association was observed in the North-American cohort. CONCLUSIONS: Our data suggest that circulating NAMPT levels are associated with CAD in type 2 diabetic patients. NAMPT rs9770242 polymorphism may be associated with CAD in some populations.
Keywords : NAMPT Visfatin Coronary artery disease Type 2 diabetes rs9770242
Type de document :
Article dans une revue
Cardiovascular Diabetology, BioMed Central, 2013, 12 (1), pp.119. 〈10.1186/1475-2840-12-119〉
Liste complète des métadonnées

Littérature citée [40 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00868742
Contributeur : Ed. Bmc <>
Soumis le : mardi 1 octobre 2013 - 21:20:39
Dernière modification le : mardi 11 octobre 2016 - 13:45:07
Document(s) archivé(s) le : lundi 6 janvier 2014 - 09:41:41

Fichiers

1475-2840-12-119.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

USPC

Citation

Pedro Saddi-Rosa, Carolina Oliveira, Felipe Crispim, Fernando Giuffrida, Valter De Lima, et al.. Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects.. Cardiovascular Diabetology, BioMed Central, 2013, 12 (1), pp.119. 〈10.1186/1475-2840-12-119〉. 〈inserm-00868742〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

451

Téléchargements de fichiers

487

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD